AADR vs CHNA

AADR is an ETF, whereas CHNA is a mutual fund. AADR has a higher expense ratio than CHNA (1.1% vs 0.79%). Below is the comparison between AADR and CHNA.

	AADR	CHNA
Security Type	ETF	Mutual fund
Segment	Equity: Global Ex-U.S. - Total Market Growth	N/A
Issuer	AdvisorShares	Loncar Investments
Net Assets	$69.25M	$11.1M
Expense Ratio	1.10%	0.79%
Management Style	passive (index-based)	passive
Dividend Yield	0.68%	0.13%
Minimum Investment	N/A	N/A
YTD Return	7.55%	23.61%
1-Year Return	14.38%	27.65%
3-Year Return	1.15%	N/A
5-Year Return	8.92%	N/A
10-Year Return	7.88%	N/A

AADR description

The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.

AADR performance & returns

YTD Return	7.55%
1-Month Return	4.62%
3-Month Return	2.30%
1-Year Return	14.38%
3-Year Return	1.15%
5-Year Return	8.92%
10-Year Return	7.88%

AADR expense ratio is 1.1%.

AADR holdings

Top 10 Holdings (45.63% of Total Assets)

Name	Symbol	% Assets
MercadoLibre Inc	MELI.SA	7.21%
NICE Ltd ADR	NICE	6.54%
Gold Fields Ltd ADR	GFI.JO	5.86%
argenx SE ADR	ARGX	5.52%
Anglogold Ashanti Ltd ADR	AU.JO	3.64%
TAL Education Group ADR	TAL	3.63%
ASML Holding NV ADR	ASML	3.59%
ZTO Express (Cayman) Inc ADR	ZTO	3.35%
Sibanye Stillwater Ltd ADR	SBSW.JO	3.21%
LVMH Moet Hennessy Louis Vuitton SE ADR	LVMUY.PA	3.08%

Other relevant AADR comparisons

You may also want to check out the following AADR comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

CHNA description

The Fund seeks to track the performance of the Loncar China BioPharma Index. The Fund invests at least 80% of its assets in the component securities of the Index constructed from the universe of Nasdaq- or Hong Kong Stock Exchange-listed companies identified by the Index methodology as Biopharma Companies.

CHNA performance & returns

YTD Return	23.61%
1-Month Return	3.35%
3-Month Return	-3.25%
1-Year Return	27.65%
3-Year Return	N/A
5-Year Return	N/A
10-Year Return	N/A

CHNA expense ratio is 0.79%.

CHNA holdings

Top 10 Holdings (32.44% of Total Assets)

Name	Symbol	% Assets
BeiGene Ltd ADR	BGNE	4.09%
WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S	02269	4.02%
Pharmaron Beijing Co Ltd Ordinary Shares - Class H	03759	4.02%
Hansoh Pharmaceutical Group Co Ltd	03692	3.37%
Wuxi AppTec Co Ltd	02359	3.14%
I-MAB ADR	IMAB	3.14%
Burning Rock Biotech Ltd ADR	BNR	2.89%
Shanghai Junshi Biosciences Co Ltd Class H	01877	2.75%
CSPC Pharmaceutical Group Ltd	01093	2.53%
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H	02196	2.49%

Other relevant CHNA comparisons

You may also want to check out the following CHNA comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.